This is the authors' abstract. We don't add key points for this paper.
Objective: According to the results of the Türkiye Health Survey; While the rate of individuals aged 15 and over who use tobacco products every day was 28.0% in 2019, it increased to 28.3% in 2022. According to the World Health Organization (WHO), smoking is the cause of death for more than 8 million people each year. The use of tobacco and tobacco products is an important health problem that harms individuals and societies, has attracted attention all over the world in recent years, and needs to be treated. In our study, it was aimed to evaluate the addiction status of individuals applying to our outpatient clinics, to determine what measures should be taken for the treatment of smoking and to determine if there is a regional awareness in the addiction score. Methods: Our study, which was planned as a cross-sectional, descriptive and prospective study, included 184 people over the age of 18, who were active smoking and who accepted to participate in the study, who applied to Ordu University Medical Faculty Family Medicine Polyclinic between 12.10.2021 and 15.01.2022 for any reason. The Fagerström Nicotine Dependence Test was used in the analysis of the addiction score. In the study, chi-square analysis was used to determine whether the Fagerström Nicotine Addiction Test Questions of Smoker Patients in the Family Medicine Outpatient Clinic changed according to the gender and age of the patients. The SPSS 21.0 V. statistical package program was used for all statistical calculations. It was considered that the research findings were significant at the P
No takes yet. Share an insight, caveat, or question.
Akyol et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: